Norris Medicines Limited

BSE:524414 Stock Report

Market Cap: ₹184.0m

Norris Medicines Management

Management criteria checks 3/4

Norris Medicines' CEO is Vimal Shah, appointed in Apr 2015, has a tenure of 9.67 years. directly owns 23.6% of the company’s shares, worth ₹43.43M. The average tenure of the management team and the board of directors is 9.7 years and 0.7 years respectively.

Key information

Vimal Shah

Chief executive officer

₹600.0k

Total compensation

CEO salary percentagen/a
CEO tenure9.7yrs
CEO ownership23.6%
Management average tenure9.7yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Vimal Shah's remuneration changed compared to Norris Medicines's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-₹8m

Jun 30 2024n/an/a

-₹9m

Mar 31 2024₹600kn/a

-₹12m

Dec 31 2023n/an/a

-₹19m

Sep 30 2023n/an/a

-₹18m

Jun 30 2023n/an/a

-₹19m

Mar 31 2023₹600kn/a

-₹17m

Dec 31 2022n/an/a

-₹34m

Sep 30 2022n/an/a

-₹34m

Jun 30 2022n/an/a

-₹36m

Mar 31 2022₹600kn/a

-₹33m

Dec 31 2021n/an/a

-₹42m

Sep 30 2021n/an/a

-₹43m

Jun 30 2021n/an/a

-₹48m

Mar 31 2021₹600kn/a

-₹50m

Dec 31 2020n/an/a

-₹23m

Sep 30 2020n/an/a

-₹28m

Jun 30 2020n/an/a

-₹26m

Mar 31 2020₹600k₹600k

-₹28m

Dec 31 2019n/an/a

-₹14m

Sep 30 2019n/an/a

-₹20m

Jun 30 2019n/an/a

-₹14m

Mar 31 2019₹600k₹600k

-₹17m

Dec 31 2018n/an/a

-₹25m

Sep 30 2018n/an/a

-₹20m

Jun 30 2018n/an/a

-₹24m

Mar 31 2018₹600k₹600k

-₹25m

Compensation vs Market: Vimal's total compensation ($USD7.04K) is below average for companies of similar size in the Indian market ($USD42.16K).

Compensation vs Earnings: Vimal's compensation has been consistent with company performance over the past year.

CEO

Vimal Shah (48 yo)

9.7yrs

Tenure

₹600,000

Compensation

Mr. Vimal Dhirendra Shah has been Managing Director at Norris Medicines Ltd. since April 1, 2015. Mr. Shah was the Chairman of Norris Medicines Limited since April 01, 2017 and its Executive Director since...

Leadership Team

NamePositionTenureCompensationOwnership
Vimal Shah
MD & Executive Director9.7yrs₹600.00k23.6%
₹ 43.4m
Iqubal Patel
Chief Financial Officer9.8yrs₹627.00kno data
Bharat Shah
General Manager of Operationsno datano datano data
Priyanka Lohiya
Company Secretary & Compliance Officerless than a yearno datano data
Manish Seth
General Manager of Marketingno datano datano data

9.7yrs

Average Tenure

57.5yo

Average Age

Experienced Management: 524414's management team is seasoned and experienced (9.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Vimal Shah
MD & Executive Director12.8yrs₹600.00k23.6%
₹ 43.4m
Praveenchand Bafna
Non-Executive Directorless than a yearno datano data
Angamuthu Vadivel
Non-Executive Independent Directorless than a yearno datano data

0.7yrs

Average Tenure

51yo

Average Age

Experienced Board: 524414's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 11:49
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Norris Medicines Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution